PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Offering a more affordable fitness class solution through training small groups and providing unparalleled client care with 1-on-1 personal training sessions. Outrivals has grown rapidly since launching 3 years ago near the famous Old Street Roundabout and are raising funds to open 2 new sites, with plans to have a portfolio of 15 branches over the next 5 years. The company has a high retention rate, with a client life cycle averaging one year.
days to go:
Expired
investment:
£88,450
Drop Bear Beer Co. aims in disrupting and exciting the alcohol-free beer market. It is the only female-run alcohol-free craft beer company. Drop Bear Beer Co.'s May 2019 launch was a success as it experienced sales of 3000 units in one month. The company is a winner of the Wales Start-Up of the Year Awards 2019. With the proceeds, Drop Bear Beer Co. will finalise core range within 12 months, scale-up production, make range available in cans, and arrange a large brand-building campaign.
days to go:
Expired
investment:
£172,570
In My Kitchen is a platform that aims to bring together a network of professional and semi-professional chefs to sell their signature dishes and recipes online. The platform was founded in July 2020. In My Kitchen asserts that its business model holds precedence in a time where takeaways have grown in popularity in the UK because of COVID-19. It gives many chefs who have become unemployed or have fewer shifts for developing their creativity and skills whilst allowing them to earn through the gig-economy. The company has a network of more than 70 chefs across London, with backgrounds across a range of cuisines. With the investment received, the company will develop its team and company infrastructure.
days to go:
Expired
investment:
Withheld
DMALINK, an electronic trading platform, fosters a transparent currency market for institutional FX and cryptocurrency traders, achieving over $8 billion monthly transactions since its Q4 '22 techstack launch, collaborating with major institutions and holding proprietary intellectual property.
days to go:
Expired
investment:
£480,856
Nebeus aims to bridge the gap between cryptocurrency and cash, providing people with instant crypto-backed cash services for everyday use. The company argues that there is an equivalent of $400 billion held in more than 55 million crypto wallets around the world which cannot be used further than keeping as an investment. It aims to change this scenario. Nebeus's core product is its 'Instant Loans' offering. It also offers users to do mobile top-ups, conduct Card2Card transfers, and send cash to Points of Sale (PoS) amongst other financial services. The company is working to come out with a 'Nebeus Mastercard' in partnership with Railsbank in Q1 of 2021. Nebeus has more than 60,000 users on its portal and has overseen transactions over £30 million to date. The company has featured in publications like The Independent, Forbes, and Bloomberg to name a few. It will use the investment for growth and marketing, the rollout of Nebeus Mastercard rollout, for growing its team, and for Research and Development (R&D).
days to go:
Expired
investment:
£862,580
